Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01507207 · ClinicalTrials.gov registry record · Phase 4
Pediatric Dysphagia Outcomes After Injection Laryngoplasty for Type I Laryngeal Cleft
A Phase 4 study of Quality of Life and Dysphagia, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT01507207: Completed Phase 4 study of Quality of Life and Dysphagia, sponsored by Oregon Health and Science University.
NCT01507207 is a Phase 4 study of Quality of Life and Dysphagia that has completed, run by Oregon Health and Science University. The registered enrollment target is 50 participants, below the 452-participant average among 107 other Quality of Life trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01507207, a Phase 4 study of Quality of Life and Dysphagia, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Type I laryngeal cleft evaluation and treatment in the pediatric population is an emerging science. The largest published series of pediatric patients with type I laryngeal clefts shows conflicting evidence in terms of outcomes, resolution of dysphagia and method of treatment. A comparison of quality of life outcomes before and after injection laryngoplasty has not been carried out. The investigators hypothesize that injection laryngoplasty significantly improves symptoms and quality of life related to dysphagia in a pediatric population with laryngeal clefts.
Primary Outcome
Measured via previously validated pediatric quality of life survey for dysphagia
Conditions Studied
Interventions
- PROCEDURE Injection laryngoplasty
Study Locations (1)
Oregon
- Oregon Health & Science University - Doernbecher Children's Hospital - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2012-01 |
| Est. Completion | 2015-05-15 |
| Phase | Phase 4 |
What the finished NCT01507207 record still lists
NCT01507207 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 452-participant average among 107 other Quality of Life trials with a reported enrollment target (89% lower).
The record links to 3 conditions, with Quality of Life appearing as the primary indexed condition, and to 1 intervention - of which Injection laryngoplasty is the first listed.
NCT01507207 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT01507207 about?
NCT01507207 is a clinical study titled "Pediatric Dysphagia Outcomes After Injection Laryngoplasty for Type I Laryngeal Cleft". Type I laryngeal cleft evaluation and treatment in the pediatric population is an emerging science. The largest published series of pediatric patients with type I laryngeal clefts shows conflicting evidence in terms of outcomes, resolution of dysphagia and method of treatment. A comparison of qualit...
What is the current status of trial NCT01507207?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2012-01. Estimated completion is 2015-05-15.
What conditions does trial NCT01507207 study?
This clinical trial studies the following conditions: Quality of Life, Dysphagia, Aspiration.
What interventions are being tested in trial NCT01507207?
The interventions under investigation include: Injection laryngoplasty (PROCEDURE).
Who is sponsoring clinical trial NCT01507207?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01507207 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Quality of Life
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01507207's enrollment target sits among peer trials
50 71st of 107 higher than 34 of 107 other Quality of Life trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Quality of Life trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preemptive Ibuprofen Effects on Pain Perception Following Extraction and Bone Graft
RECRUITING · Phase 4
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Development of a Multi-sensory Rehabilitation Program for People With Ultra Low Vision
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
-
A Cardiac Disease Quality of Life Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia